United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet
Go back to United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 487.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $487.61 | 52 Week High | $164.04 | |||
| Open | $487.61 | 52 Week Low | $97.52 | |||
| Day High | $487.61 | P/E | 89.14 | |||
| Day Low | $487.61 | EPS | $5.47 | |||
| Volume | 2 | |||||
